Jeffrey Thomas Perez net worth and biography

Jeffrey Perez Biography and Net Worth

SVP of Precigen
Mr. Jeffrey Perez serves as Senior Vice President, Intellectual Property Affairs for Precigen. Before joining the company, Mr. Perez was with Third Security LLC, where he evaluated potential investments of Third Security’s managed investment funds. Additionally, Mr. Perez worked with Third Security portfolio companies in evaluating and developing their intellectual property strategies and general corporate activities. Prior to joining Third Security, Mr. Perez practiced intellectual property law with the law firm of Hunton & Williams LLP in Washington D.C. Mr. Perez’s previous work involved client consultation, litigation, agreement work, opinion drafting and patent procurement. Mr. Perez received a BS degree from Cornell University and JD from George Mason University School of Law.

What is Jeffrey Thomas Perez's net worth?

The estimated net worth of Jeffrey Thomas Perez is at least $697,251.96 as of January 27th, 2023. Mr. Perez owns 381,012 shares of Precigen stock worth more than $697,252 as of February 5th. This net worth approximation does not reflect any other investments that Mr. Perez may own. Learn More about Jeffrey Thomas Perez's net worth.

What is Jeffrey Thomas Perez's salary?

As the SVP of Precigen, Inc., Mr. Perez earned a total compensation package of $778,536.00 in 2021. Mr. Perez earned a salary of $500,000.00, a bonus of $70,000.00, stock awards of $174,994.00, and other compensation of $33,542.00. Learn More on Jeffrey Thomas Perez's salary.

How do I contact Jeffrey Thomas Perez?

The corporate mailing address for Mr. Perez and other Precigen executives is 20374 Seneca Meadows Parkway, Germantown MD, 20876. Precigen can also be reached via phone at (301) 556-9900 and via email at [email protected] Learn More on Jeffrey Thomas Perez's contact information.

Has Jeffrey Thomas Perez been buying or selling shares of Precigen?

During the last ninety days, Jeffrey Thomas Perez has bought $49,999.25 of Precigen stock. Most recently, on Friday, January 27th, Jeffrey Thomas Perez bought 28,571 shares of Precigen stock. The stock was acquired at an average cost of $1.75 per share, with a total value of $49,999.25. Following the completion of the transaction, the senior vice president now directly owns 381,012 shares of the company's stock, valued at $666,771. Learn More on Jeffrey Thomas Perez's trading history.

Who are Precigen's active insiders?

Precigen's insider roster includes Randal Kirk (Director), Donald Lehr (Insider), David Obstler (CFO), Jeffrey Perez (SVP), Helen Sabzevari (CEO), and Harry Thomasian, Jr. (CFO). Learn More on Precigen's active insiders.

Are insiders buying or selling shares of Precigen?

In the last year, Precigen insiders bought shares 5 times. They purchased a total of 11,513,641 shares worth more than $20,157,201.75. In the last year, insiders at the biotechnology company sold shares 5 times. They sold a total of 263,661 shares worth more than $372,468.96. The most recent insider tranaction occured on January, 27th when COO Rutul R Shah bought 9,142 shares worth more than $15,998.50. Insiders at Precigen own 43.7% of the company. Learn More about insider trades at Precigen.

Information on this page was last updated on 1/27/2023.

Jeffrey Thomas Perez Insider Trading History at Precigen

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
1/27/2023Buy28,571$1.75$49,999.25381,012View SEC Filing Icon  
5/17/2022Sell14,778$1.28$18,915.84333,502View SEC Filing Icon  
1/5/2022Sell9,738$3.59$34,959.42View SEC Filing Icon  
1/3/2022Sell5,022$3.67$18,430.74View SEC Filing Icon  
1/5/2021Sell9,049$10.56$95,557.44288,870View SEC Filing Icon  
12/16/2020Sell9,382$7.20$67,550.40268,229View SEC Filing Icon  
9/16/2020Sell7,660$5.22$39,985.20250,889View SEC Filing Icon  
1/2/2020Sell4,366$5.60$24,449.6066,705View SEC Filing Icon  
10/1/2019Sell4,521$5.50$24,865.5056,886View SEC Filing Icon  
8/11/2017Buy1,000$17.89$17,890.0012,537View SEC Filing Icon  
See Full Table

Jeffrey Thomas Perez Buying and Selling Activity at Precigen

This chart shows Jeffrey Thomas Perez's buying and selling at Precigen by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Precigen Company Overview

Precigen logo
Precigen, Inc. is a biotechnology company, which engages in the research and development of synthetic biology technologies. It operates through the following segments: Biopharmaceuticals, Exemplar, and Trans Ova. The Biopharmaceuticals segment is involved in advancing the next generation of gene and cell therapies using precision technology to target urgent and intractable diseases in immuno-oncology, autoimmune disorders, and infectious diseases. It also engages in pioneering a proprietary class of microbe-based biopharmaceuticals that enable expression and local delivery of disease-modifying therapeutics. The Exemplar segment is focused on developing research models and services for healthcare research applications. The Trans Ova segment provides bovine reproductive technologies. The company was founded by Thomas David Reed in 1998 and is headquartered in Germantown, MD.
Read More

Today's Range

Now: $1.83
Low: $1.76
High: $1.88

50 Day Range

MA: $1.67
Low: $1.27
High: $2.19

2 Week Range

Now: $1.83
Low: $1.12
High: $2.90

Volume

2,644,131 shs

Average Volume

2,652,622 shs

Market Capitalization

$459.35 million

P/E Ratio

15.25

Dividend Yield

N/A

Beta

1.87